Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adavosertib with Cisplatin in Recurrent or Metastatic Head and Neck Cancer
NCT02196168Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Mar 2014; status: terminated.
02
Drugs
adavosertib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02196168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196168.